NumFin

Jiangsu Apon Medical Technology Co., Ltd.

Sümbol: 300753.SZ

SHZ

12.98

CNY

Turuhind täna

  • -103.9099

    P/E suhe

  • 0.0000

    PEG suhe

  • 1.64B

    MRK Cap

  • 0.00%

    DIV tootlus

Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Jiangsu Apon Medical Technology Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

0249.3274.7388.6
420.6
436.1
169.8
141.7
74.1
12.2

balance-sheet.row.short-term-investments

0-22.7-7.6-1.5
-0.9
-1.5
0
0
0
0

balance-sheet.row.net-receivables

0133.6139.2102.3
90.7
55.2
39.9
37.3
36.4
30.5

balance-sheet.row.inventory

06167.431.7
27.9
25.4
24.3
20.9
13.2
13.4

balance-sheet.row.other-current-assets

01.52.90.7
0.3
1.2
0.4
1.2
4.4
25.5

balance-sheet.row.total-current-assets

0445.4484.2523.3
539.5
517.9
234.4
201.1
128
81.5

balance-sheet.row.property-plant-equipment-net

0207212.8168.6
143.7
99.2
38.1
39.2
31.5
31.7

balance-sheet.row.goodwill

053.269.433.9
16.5
16.5
16.5
16.5
0
0

balance-sheet.row.intangible-assets

035.633.237.7
43
32.5
37.5
32.5
2
2.1

balance-sheet.row.goodwill-and-intangible-assets

088.8102.671.6
59.5
49
54
49
2
2.1

balance-sheet.row.long-term-investments

0103.88760.5
7.8
2.5
3.4
2.8
0.5
0

balance-sheet.row.tax-assets

024.48.72.1
3.2
3.1
2.4
2.3
2.3
0.1

balance-sheet.row.other-non-current-assets

00.83.71.2
3.9
16.3
4.3
3
16.5
0.5

balance-sheet.row.total-non-current-assets

0424.8414.9303.9
218.2
170.1
98.8
93.4
52.2
34.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0

balance-sheet.row.total-assets

0870.2899.1827.2
757.6
688
333.3
294.5
180.3
115.8

balance-sheet.row.account-payables

046.927.831.4
30.4
29.1
4.7
4.3
2.3
5.9

balance-sheet.row.short-term-debt

033.82-3.4
-5.2
0
0
0
3
3

balance-sheet.row.tax-payables

06.68.514.5
14.3
5.9
8.9
10.8
10.2
8.9

balance-sheet.row.long-term-debt-total

034.539.93.7
0
0
0
0
0
0

Deferred Revenue Non Current

01.922
2
2.5
0.7
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01.642.353.8
49.8
42.9
48.5
60.6
29.5
25.5

balance-sheet.row.total-non-current-liabilities

036.7422.2
2.5
2.6
0.7
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

034.539.93.7
0
0
0
0
0
0

balance-sheet.row.total-liab

0183.9118.587.4
82.8
74.6
53.9
64.9
34.9
34.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

0126126105
80.8
80.8
60.6
60.6
28.6
26.7

balance-sheet.row.retained-earnings

0188.1264.5247.1
191.4
132.6
68.7
26.3
55.8
37.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

041.541.536.5
27.5
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0329.9347.6350.9
375.2
391.4
142.6
137
56.6
13.7

balance-sheet.row.total-stockholders-equity

0685.6779.6739.5
674.9
604.9
271.8
223.9
141
77.5

balance-sheet.row.total-liabilities-and-stockholders-equity

0870.2899.1827.2
757.6
688
333.3
294.5
180.3
115.8

balance-sheet.row.minority-interest

00.80.90.3
0
8.5
7.5
5.7
4.4
3.9

balance-sheet.row.total-equity

0686.4780.5739.8
674.9
613.4
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

081.179.459
6.9
1
1.6
1.9
0
0

balance-sheet.row.total-debt

068.439.93.7
0
0
0
0
3
3

balance-sheet.row.net-debt

0-180.9-234.8-384.8
-420.6
-436.1
-169.8
-141.7
-71.1
-9.2

Rahavoogude aruanne

Jiangsu Apon Medical Technology Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

cash-flows.row.net-income

0-76.553.396.9
102.8
71.1
60.2
49.3
29.7
0

cash-flows.row.depreciation-and-amortization

019.615.49.7
9.7
9.2
9
8.7
3
0

cash-flows.row.deferred-income-tax

0-15.5-6.60.7
0.2
0
0
0
0
0

cash-flows.row.stock-based-compensation

015.56.6-0.7
-0.2
0
0
0
0
0

cash-flows.row.change-in-working-capital

028.3-76.7-25.8
-18.6
-5
-2.1
5
-10.1
0

cash-flows.row.account-receivables

09.1-47.6-34
-43
0
0
0
0
0

cash-flows.row.inventory

06.3-33.6-3.3
-7.6
-1.1
-3.5
-4.1
0.2
0

cash-flows.row.account-payables

028.411.110.7
31.8
0
0
0
0
0

cash-flows.row.other-working-capital

0-15.5-6.60.7
0.2
-3.9
1.4
9.2
-10.3
0

cash-flows.row.other-non-cash-items

04.126.32.6
-16.4
2.9
-0.1
-2.1
15.5
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-24.2-39.6-35.6
-58.3
-61.6
-15.7
-4.3
-3.1
-2.7

cash-flows.row.acquisitions-net

00.1-37.32.7
7.2
-11.2
-14
-20.6
-16
0

cash-flows.row.purchases-of-investments

0-3-22.5-52.4
-6.6
0
-166
-157.5
-27.4
-63.1

cash-flows.row.sales-maturities-of-investments

02590.10.8
0.1
0
167.2
160.8
48.8
57.6

cash-flows.row.other-investing-activites

0-256.72.51.5
0.5
0
0
1.4
1.7
-1.4

cash-flows.row.net-cash-used-for-investing-activites

0-24.8-96.7-83.1
-57.1
-72.8
-28.4
-20.3
4
-9.5

cash-flows.row.debt-repayment

0-29.40-0.4
0
0
0
-3
-3
-15

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-0.6-31.5-32.3
-32.3
0
-10
-16.2
-7.1
-3.4

cash-flows.row.other-financing-activites

054-4.30.4
-3.8
260.7
-0.4
45.9
30
1.1

cash-flows.row.net-cash-used-provided-by-financing-activities

023.9-35.8-32.3
-36.1
260.7
-10.4
26.7
19.8
-17.3

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0.3
-0.1
0.2
0
0

cash-flows.row.net-change-in-cash

0-25.5-114.3-32
-15.5
266.3
28.1
67.6
61.9
6.7

cash-flows.row.cash-at-end-of-period

0248.8274.3388.6
420.6
436.1
169.8
141.7
74.1
12.2

cash-flows.row.cash-at-beginning-of-period

0274.3388.6420.6
436.1
169.8
141.7
74.1
12.2
5.4

cash-flows.row.operating-cash-flow

0-24.618.383.3
77.6
78.1
67.1
61
38.1
0

cash-flows.row.capital-expenditure

0-24.2-39.6-35.6
-58.3
-61.6
-15.7
-4.3
-3.1
-2.7

cash-flows.row.free-cash-flow

0-48.8-21.347.7
19.3
16.5
51.4
56.6
35
-2.7

Kasumiaruande rida

Jiangsu Apon Medical Technology Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 300753.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

income-statement-row.row.total-revenue

0323.8461.2443.1
379.6
298
246.9
198.3
153.5
120.4

income-statement-row.row.cost-of-revenue

0163.8166.3188.6
112
70
62.3
50.9
40.1
33.9

income-statement-row.row.gross-profit

0160294.9254.5
267.6
228
184.6
147.4
113.4
86.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.operating-expenses

0232235.5146.3
171.9
141.4
115
100.7
85.2
50.5

income-statement-row.row.cost-and-expenses

0395.7401.8334.9
283.9
211.5
177.3
151.7
125.3
84.3

income-statement-row.row.interest-income

02.13.67.2
7.4
1
0.3
0.1
0
0

income-statement-row.row.interest-expense

02.51.10
0.1
1.1
0.1
0
0.1
0.7

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.total-operating-expenses

0-2.4-0.5-1.6
-2.9
-1.8
-0.9
8.4
6.1
4.2

income-statement-row.row.interest-expense

02.51.10
0.1
1.1
0.1
0
0.1
0.7

income-statement-row.row.depreciation-and-amortization

019.615.49.7
9.7
9.2
9
8.7
3
2.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0-88.355.8113.5
120.7
85.6
70.7
49.1
27.3
34.8

income-statement-row.row.income-before-tax

0-90.755.3111.9
117.8
83.7
69.8
57.5
33.4
39

income-statement-row.row.income-tax-expense

0-14.2215
15
12.7
9.6
8.2
3.7
6.8

income-statement-row.row.net-income

0-76.454.197
102.3
70.1
57.9
47.7
28.9
31.4
Sarnased aktsiad
Sind võib huvitada ka:
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
BLCO
Bausch + Lomb Corporation.
15.29 USD
NYSE
137310.KS
SD BioSensor, Inc.
10740 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
7.56 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.69 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
ALC.SW
Alcon Inc..
72.94 CHF
SIX
8086.T
Nipro Corporation.
1256 JPY
JPX
6929.HK
OrbusNeich Medical Group Holdings Limited.
4.42 HKD
HKSE

Korduma kippuv küsimus

Mis on Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) koguvara?

Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) koguvara on 870213234.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.567.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.266.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.043.

Mis on ettevõtte kogutulu?

Kogutulu on -0.061.

Mis on Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -76377405.540.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 68373296.000.

Mis on tegevuskulude arv?

Tegevuskulud on 231973871.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.